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www.jacctctabstracts2014com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMResults: Patients were aged 83  6 years, 50% were male, with a log EuroSCORE II
8  5.8 and 82% being in NYHA class III or IV. The CoreValve aortic valve pros-
thesis was used in all patients, and all procedures were done without general anes-
thesia. No differences were found between SP and DP group in clinical and procedural
characteristics. Primary endpoint occurred in 25% (n¼16) of the SP patients and in 5%
(n¼3) of DP patients (p< 0.001) (Figure). Postprocedure Hb-fall was 20.0 g/L ( 13)
in the SP and 14.3 g/L ( 8) in the DP group (p< 0,005).Conclusions: The double Prostar XL large arterial closure technique during TAVI
was associated with less access-site related vascular complication and less blood loss
compared with single Prostar XL.
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Background: We have previously demonstrated the safety and efﬁcacy of our hybrid
closure (HC) technique which employs the combination of 1 “pre-closed” Perclose (P)
suture mediated vascular closure device (VCD) followed by the deployment of a 6
French (Fr) Mynx or 6 Fr Angioseal to effect hemostasis in up to 14 Fr arteriotomies
(AR) in patients undergoing high risk coronary intervention with Impella 2.5 or CP
support via the common femoral artery (CFA). We further sought to determine if this
method could also reliably achieve hemostasis in the setting of transfemoral (TF)
transcatheter aortic valve replacement (TAVR) utilizing an expandable sheath (e-
sheath) with an outer diameter of 16Fr and in the setting of the use of alternate large
bore AR sites, namely the axillary artery (AA).
Methods: 4 patients undergoing TF-TAVR and 1 patient undergoing high risk PCI
with Impella 2.5 support inserted via the left axillary artery (AA) due to severe pe-
ripheral vascular disease had their large bore AR closed in the following manner. Post-
procedure, the 16 Fr e-sheath or 13 Fr Impella sheath was removed and a 0.035” wire
was inserted into the vessel through the sheath. As the sheath was withdrawn the
vessel was “partially pre-closed” with 1 P device. For the 16 Fr AR, an 8 Fr sheath
was advanced over the 0.035 wire achieving temporary hemostasis, and effectively
reducing a 16Fr to a 8Fr AR site. The 8Fr AR site was then simply closed with an 8 Fr
Angioseal vascular closure device. For the 13 Fr AR in the left AA a 6 Fr sheath was
inserted after deployment of the P and a 6 Fr sheath and angioseal VCD used. An-
giograms of all AR sites were performed after HC. Follow up was done the next day
and at 30 days.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/VaResults: Hybrid closure was successful in achieving complete hemostasis in all 4 TF-
TAVR cases and in the high-risk Impella supported PCI via the left AA. All patients
who underwent HC were free of complications at day 1 and 30 post-procedure.
Conclusions: HC is a simple and safe alternative to the traditional “pre-close” tech-
nique. HC is also reliable in effecting hemostasis in patients undergoing TF-TAVR
and in closure of large bore AR of the AA. Larger studies are needed to validate our
ﬁndings.
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Background: Direct comparison of transfemoral (TF) and transapical (TA) accesses
for Transcatheter Aortic Valve Replacement (TAVR) is troublesome due to hetero-
geneity in outcome deﬁnitions between studies. We used applied standardized Valve
Academic Research Consortium (VARC) deﬁnition of vascular complications to
perform an updated meta-analysis for patients receiving Edwards SAPIEN TAVR via
TF and TA approaches.
Methods: Pubmed and Scopus databases were searched for studies that compared the
incidence of major vascular complications in TF and TA accesses in Edwards SA-
PIEN TAVR procedures. Random-effects model was used to calculate the relative
risk. Heterogeneity was assessed with Higgins and Thompson I2 statistic. All analyses
were performed using STATA 11.2 (Texas, USA).
Results: Fourteen studies met all inclusion criteria. A total of 2,526 patients were
included, of which 1,337 (52.9%) had TF TAVR. As illustrated in ﬁgure 1, the pooled
risk of major vascular complications with the TF access was signiﬁcantly higher than
the TA approach (17.2% x 5.2%, respectively; RR 2.94, 95% CI 2.08-4.14). This
difference was consistent among studies that predated VARC criteria (RR 3.18, 95%
CI 1.86-5.45) and those that adopted VARC standardized outcome deﬁnitions (RR
2.48; 95% CI 1.68-3.64).
Conclusions: In this updated meta-analysis, TF access was associated with a signif-
icantly higher incidence of 30-day major vascular complications when compared to
the TA technique. This difference persisted in studies that used standardized VARC
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